10 citations · 36 across the 10 of their papers we have counts for
Showing 2023Show all
2 papers · 1 filter
stat.AP2023
Estimands in Real-World Evidence Studies
Jie Chen, Daniel Scharfstein, Hongwei Wang +6
A Real-World Evidence (RWE) Scientific Working Group (SWG) of the American Statistical Association Biopharmaceutical Section (ASA BIOP) has been reviewing statistical consideration…
stat.ME2023★ 4 cited
Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects
Trang Quynh Nguyen, Elizabeth A. Stuart, Daniel O. Scharfstein +1
An important strategy for identifying principal causal effects, which are often used in settings with noncompliance, is to invoke the principal ignorability (PI) assumption. As PI…